“If this blog helped you out, don’t keep it to yourself—share the link on your socials!” 👍 “Like what you read? Spread the love and share this blog on your social media.” 👍 “Found this useful? Hit share and let your friends know too!” 👍 “If you enjoyed this post, please share the URL with your friends online.” 👍 “Sharing is caring—drop this link on your social media if it helped you.”

Sunday, August 31, 2025

Concordia Pharmaceuticals


Concordia Pharmaceuticals products


D

  • Dibenzyline — phenoxybenzamine
    Indication: management of pheochromocytoma (a rare neuroendocrine tumor tied to hypertension)

  • Donnatal — atropine/hyoscyamine/phenobarbital/scopolamine
    Indication: motion sickness, irritable bowel symptoms—a combination of antispasmodics and sedatives

  • Dyrenium — triamterene
    Indication: potassium-sparing diuretic used in hypertension and edema management

K

  • Kapvay — clonidine (extended-release)
    Indication: treatment of attention-deficit/hyperactivity disorder (ADHD)

L

  • Lanoxin — digoxin
    Indication: used in heart failure and certain arrhythmias (atrial fibrillation)

N

  • Nilandron — nilutamide
    Indication: treatment of metastatic prostate cancer (antiandrogen therapy)

O

  • Orapred ODT — prednisolone (orally disintegrating tablet)
    Indication: corticosteroid for inflammatory and immune-mediated conditions

P

  • Parnate — tranylcypromine
    Indication: monoamine oxidase inhibitor (MAOI) used in depression

  • Plaquenil — hydroxychloroquine
    Indication: antimalarial agent also used in autoimmune conditions such as rheumatoid arthritis and lupus

U

  • Uroxatral — alfuzosin
    Indication: treatment of benign prostatic hyperplasia (BPH)

Z

  • Zonegran — zonisamide
    Indication: anticonvulsant used as adjunctive therapy for partial seizures




on

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)